Shares of Cibus, Inc. fell significantly Tuesday morning after Bonitas Research issued a report alleging that they "found no evidence that Cibus' gene-editing technology brings desirable new crops to market." Bonitas did find "farmer complaints of lower crop yields and lost revenues, along with multiple examples of large seed manufacturers and distributors walking away from joint ventures and partnerships with Cibus for a variety of seed types and seed traits." Block & Leviton is investigating these allegations.
Contact our attorneys for a no-cost case evaluation.